Influenza Diagnostics Market to grow at 5.8% CAGR between 2017 and 2023

 

Market Overview:

Influenza as an illness can cause severe complications and mess up anybody's medical history. Influenza is of various types and with a variety of deadly symptoms. Hence, early diagnosis of influenza can reduce the chances of further complications. Therefore, with World Health Organization (WHO) confirming about 600 million Influenza cases worldwide, the services offering accurate Influenza diagnosis are going to be in-demand always and become a part of a huge market in the medical sector.

Market Research Future (MRFR) has published a report about the global Influenza Diagnostics Market. This report expects 5.8% CAGRduring the forecast period between 2017 and 2023. In terms of cash, this market is expected to grow with US $ 700.7 mn by 2023. This report analyzes the market, potential for growth during the forecast period, market sizes around the world, key players in the market, product launches and latest research and development (R&D). The global influenza diagnostics market is on the basis of types, tests,and region.The segmentation of types comprises of type A flu, type B flu, type C flu. The three forms of type A are bird flu, seasonal flu, andSwine flu. On the basis of direct fluorescent antibody (DFA) tests, molecular tests, nucleic acid sequence-based amplification (NASBA) tests, rapid influenza detection tests (RIDT), serological assays, simple amplification-based assays (SAMBA) and loop-mediated isothermal amplification-based assays (LAMP). Serological assays are segmented into primary serological tests, secondary serological tests, and tertiary serological tests. Primary serological tests cover enzyme-linkedimmunosorbent assay (ELISA), immunofluorescent antibody technique (IFAT) and radioimmunoassay (RIA). Secondary Serological tests include agglutination tests, complement fixation tests (CFT), precipitation tests, serum neutralization tests (SNT) and toxin-antitoxin test.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/3142

The regional segmentation of the global influenza diagnostics market is into the Americas (North America & South America), Europe, Asia Pacific, and Middle East & Africa (MEA). North America is believed to be the largest market for global influenza diagnostics due to advanced healthcare facilities andthe increasing presence of major market players in this region. Compared to North America, South America is a moderately smaller market,but that is not due to lack of demand but due to the lack of awareness, lack of advanced technology and lesser budgets for healthcare. In North America, the largest markets are Canada and the United States of America (USA). After North America, Europe is the largest market for influenza diagnostics. Here due to reasons same as North America, Western Europe stands with the lion's share in Europe market, compared to Eastern Europe. In Western Europe, the biggest markets are France, Germany, Italy, Spain and the United Kingdom (UK), followed by the rest of Europe. During the forecast period, Asia Pacific region is expected to experience large-scale growth of influenza diagnostics market with China, India, Japan and South Korea emerging as major markets. Remarkable growth is also expected in remaining countries of Asia Pacific region. However, compared to the Asia Pacific, MEA is expected to have limited growth, with Egypt, Saudi Arabia and the United Arab Emirates (UAE) emerging as the best bets for influenza diagnostics market investors.The low market in the MEA region is primarily due to the lack of technology and education.

Key Players

The key players in global influenza diagnostics market include Alere (USA), BD (USA), Becton Dickinson (USA), BioMérieux SA (France), Cepheid (USA), Hardy Diagnostics(USA), LifeSign LLC.(USA), Meridian Bioscience, Inc.(USA), Quidel Corporation (USA), Roche Molecular Systems Inc.(Switzerland), and Sekisui Diagnostics (USA).

Latest Industry News

·         Medical technology company Becton Dickinson (BD), currently a key player in global influenza diagnostics market, has formally opened a new research facility at Plassey Technological Park in Limerick. This business expansion has created 85 new jobs at its Irish operations. Currently, BD employs more than 1,300 employees in Ireland across Drogheda, Dun Laoghaire and its two sites in Limerick.

US-based leading molecular diagnostics company, Cepheid Inc, a key player in global influenza diagnostics market, has unveiled its newest configuration in the GeneXpert family of systems, the GeneXpert Edge. An owned subsidiary of Danaher, Cepheid Inc, also announced its ‘Make in India’ initiative regarding which they have plans to establish their manufacturing footprint in the country for Xpert MTB/RIF test cartridges which run on the GeneXpert System.  In the last two years, more than 1,200 Cepheid’s GeneXpert Systems have been installed at various revised national tuberculosis control program (RNTCP) sites in India. Last year, more than 2.5 million cartridges were supplied at various centers of Central TB Division (CTD). The India launch of GeneXpert Edge is expected later this year.

Comments

Post a Comment

Popular posts from this blog

Gene Therapy Market Mobilizing Viral Vector Manufacturing Market

Market Overview: The global viral vector manufacturing market is expected to exhibit a strong 22.65% CAGR over the forecast period from 2018 to 2023 , according to the latest research report from Market Research Future (MRFR). The report forecasts a valuation of USD 319 million for the market by the end of the 2018-2023 forecast period. In current time, gene therapy is one of the preferred treatment options for most chronic diseases, that involves the insertion of a functional copy of a gene into a defective cell. viral vectors and the absence of the appropriate tools are likely to be the key restraints acting against the global Viral Vector Manufacturing Market Size over the forecast period. Many companies in the global viral vector manufacturing market are taking steps to counter the difficulties in producing viral vectors and this area is likely to remain a hive of activity in the coming years. This has also resulted in strong growth prospects for companies that can develop e...
Read more

Negative Pressure Wound Therapy Market is Increasing at a Healthy CAGR of 6.7% During Forecast to 2023

    MRFR Processed new research on “Negative Pressure Wound Therapy Market-Global Forecast to   Market Analysis:    The worldwide negative pressure wound therapy market is predicted to grow at a 6.7% CAGR during the forecast period (2018-2023), according to the latest Market Research Future (MRFR) report. Negative pressure wound therapy or NPWT, which is also called vacuum-assisted wound closure, includes the use of sub-atmospheric pressure for healing chronic and acute wounds. These devices come in assorted sizes and shapes to match the patient’s body contour and also the wound size to be treated. NPWT devices have a dressing set, drainage tubing, and vacuum pump that along with promoting wound healing also helps in reducing recurrent usage of dressings, offer an effective choice for managing closed surgical incision lines as well as augment the well-being of the patient.    Also Read: https://www.medgadget.com/2020/02/negative-pressur...
Read more

North Americas Uplifting 3D Printed Medical Implants Market

Market Overview: Expanding innovative advances in 3D printed implants, for example, improvement of CT-Bone, bone indistinguishable redid embed for use in mandible and zygoma increase procedure should help business development. Its controlled porosity empowers it to fit life structures of the patient, in this manner, dominatingly driving industry development. Also, increment in medicinal services consumption, ascend in R&D venture, flood in number of medical procedures and expanding extent of 3D innovation in biomedical application will spike income size during the figure time frame. In any case, factors, for example, significant expense of printers, longer creation courses of events, absence of talented representatives and absence of in-house added substance fabricating assets is relied upon to obstruct 3D printed implants market development over the coming years. The market for 3D Printed Medical Implants Market   is likely to register a CAGR of 18.1% during the foreca...
Read more